at Zacks.com (Thu, 6:20PM)
More on Becton Dickinson (BDX -3.8%) FQ4: net profit -3.6% to $289M, with earnings hurt by weak...
More on Becton Dickinson (BDX -3.8%) FQ4: net profit -3.6% to $289M, with earnings hurt by weak revenue at its biosciences and medical ops, pension settlement charges, and forex fluctuations. U.S. sales +1.2%, international -2.6%, but +7.1% excluding currency impact. Gross margin falls to 50.9% from 51.2%. Expects FY revenue growth of 2%-3% and EPS from continuing ops of $5.58-$5.64 vs consensus of +3% and $5.80.
From other sites
at Zacks.com (Jan 12, 2015)
at Nasdaq.com (Jan 9, 2015)
at Zacks.com (Jan 8, 2015)
at Zacks.com (Jan 7, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs